Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Spotlight: Apama Medical, Targeting AFib With An RF-Balloon Combo

Executive Summary

Founded and led by serial entrepreneur Amr Salahieh, Apama Medical is developing a system that aims to combine the advantages of two approaches for treating atrial fibrillation: point-by-point radiofrequency-based ablation and cryoballoon ablation.

You may also be interested in...

Boston Scientific Adds Single-Shot AF-Ablation Balloon With Apama Acquisition

Boston Scientific will pay about $300m for the Campbell, California-based maker of the Apama radiofrequency balloon catheter system for the treatment of atrial fibrillation. Boston Scientific plans to integrate Apama's technology with its Rhythmia HDx mapping system.

MNA Analysis: Abbott And Stryker Make Big Deals In Slow Month

February 2016 was a slow month for medtech mergers and acquisitions punctuated by three billion-dollar-plus deals.

Boston follows Medtronic's footsteps and buys into TAVI space

Boston Scientific is to buy outright a company in its investment portfolio, Sadra Medical. The firm specialises in percutaneous transcatheter aortic valve implantation (TAVI) technology and the acquisition follows in the footsteps of heart rival Medtronic, which last year bought two venture-backed TAVI companies – CoreValve and Ventor Technologies – for just under $1bn (, 2 March 2009).


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts